Details for Patent: 6,461,605
✉ Email this page to a colleague
Summary for Patent: 6,461,605
| Title: | Continuous low-dose cytokine infusion therapy |
| Abstract: | A method is provided for treating conditions that are susceptible of treatment with a cytokine wherein the undesirable side effects normally associated with cytokine administration are diminished or eliminated. The method comprises continuously administering a low dose of a cytokine to an individual afflicted with a condition susceptible of treatment with the cytokine. In a preferred embodiment of the invention, chronic hepatitis C is treated by administering a low dose amount of interferon. |
| Inventor(s): | Cutler; David L. (Morristown, NJ), Affrime; Melton B. (Flemington, NJ) |
| Assignee: | Schering Corporation (Kenilworth, NJ) |
| Application Number: | 10/104,287 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 6,461,605
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,461,605
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 012614 | ⤷ Sign Up | |||
| Austria | 255421 | ⤷ Sign Up | |||
| Austria | 262920 | ⤷ Sign Up | |||
| Australia | 7249098 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
